From darkness to light with biomarkers in early clinical trials of cancer drugs. (Q37371582)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19151637%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

review article

1 reference

title

From darkness to light with biomarkers in early clinical trials of cancer drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19151637%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19151637%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

C P Carden

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19151637%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

S B Kaye

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19151637%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

P Workman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19151637%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

J S de Bono

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19151637%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

English

0 references

publication date

1 February 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19151637%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19151637%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19151637%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19151637%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

131-133

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19151637%20AND%20SRC:MED&resulttype=core&format=json

Why is cancer drug discovery so difficult?

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.223

Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.223

Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.223

Pharmacodynamic biomarkers for molecular cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.223

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.223

Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.223

Signaling networks assembled by oncogenic EGFR and c-Met

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.223

Randomized phase II trial of the clinical and biological effects of two dose levels of gefitinib in patients with recurrent colorectal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.223

Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.223

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.223

Minimally invasive pharmacokinetic and pharmacodynamic technologies in hypothesis-testing clinical trials of innovative therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.223

21 January 2018

Identifiers

DOI

10.1038/CLPT.2008.223

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19151637%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference